These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24656526)

  • 1. Uveal metastasis and myasthenia gravis in a patient with recurrent renal cell carcinoma treated with pazopanib.
    Jebb A; Hadden P; Broom RJ
    Clin Genitourin Cancer; 2014 Aug; 12(4):e143-6. PubMed ID: 24656526
    [No Abstract]   [Full Text] [Related]  

  • 2. [Another approach to targeted therapy of patients with metastatic renal carcinoma with progression in treatment with pazopanib:expert assessment by the Czech Cooperative Group for Metastatic Renal Carcinoma].
    Büchler T; Finek J; Hájek J; Kocák I; Kubácková K; Lakomý R; Melichar B; Petruzelka L; Poprach A; Siffnerová M; Tomásek J; Vyzula R; Zemanová M;
    Klin Onkol; 2013; 26(1):55-7. PubMed ID: 23607143
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcomes of unselected patients with metastatic clear-cell renal cell carcinoma treated with first-line pazopanib therapy followed by vascular endothelial growth factor receptor tyrosine kinase inhibitors or mammalian target of rapamycin inhibitors: a single institution experience.
    Matrana MR; Bathala T; Campbell MT; Duran C; Shetty A; Teegavarapu P; Kalra S; Xiao L; Atkinson B; Corn P; Jonasch E; Tannir NM
    BJU Int; 2016 Aug; 118(2):264-71. PubMed ID: 26573089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity.
    Schinzari G; Monterisi S; Signorelli D; Cona MS; Cassano A; Danza F; Barone C
    Tumori; 2014; 100(6):e298-300. PubMed ID: 25688515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [First Hungarian experience with pazopanib therapy for patients with metastatic renal cancer].
    Maráz A; Bodrogi I; Csejtei A; Dank M; Géczi L; Küronya Z; Mangel L; Petrányi A; Szûcs M; Bodoky G
    Magy Onkol; 2013 Sep; 57(3):173-6. PubMed ID: 24107823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapies: treating advanced kidney cancer-miles to go before we sleep.
    Linehan WM; Srinivasan R
    Nat Rev Clin Oncol; 2013 Nov; 10(11):614-5. PubMed ID: 24129349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update.
    Sternberg CN; Hawkins RE; Wagstaff J; Salman P; Mardiak J; Barrios CH; Zarba JJ; Gladkov OA; Lee E; Szczylik C; McCann L; Rubin SD; Chen M; Davis ID
    Eur J Cancer; 2013 Apr; 49(6):1287-96. PubMed ID: 23321547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling tumor growth kinetics after treatment with pazopanib or placebo in patients with renal cell carcinoma.
    Bonate PL; Suttle AB
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):231-40. PubMed ID: 23715625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pazopanib for treatment of renal cell carcinoma and soft tissue sarcomas].
    Brotelle T; Bay JO
    Bull Cancer; 2014 Jun; 101(6):641-6. PubMed ID: 24977453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged survival of a patient with papillary renal cell carcinoma and brain metastases using pazopanib.
    Jacobs C; Kim DW; Straka C; Timmerman RD; Brugarolas J
    J Clin Oncol; 2013 Mar; 31(7):e114-7. PubMed ID: 23319695
    [No Abstract]   [Full Text] [Related]  

  • 11. Pazopanib for the treatment of renal cancer.
    Al-Marrawi MY; Rini B
    Expert Opin Pharmacother; 2011 May; 12(7):1171-89. PubMed ID: 21470066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report of a long-surviving man with metastatic renal cell carcinoma treated with pazopanib.
    Ratta R; Santini D
    Tumori; 2014; 100(2):e59-62. PubMed ID: 24852879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and prolonged response to pazopanib in a patient with multiple metastases from renal cell carcinoma: a case report.
    Biasco E; Antonuzzo A; Cianci C; Derosa L; Marconcini R; Farnesi A; Galli L
    Tumori; 2014; 100(3):e83-6. PubMed ID: 25076257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pazopanib for the treatment of renal cell carcinoma.
    Welsh SJ; Fife K
    Future Oncol; 2015; 11(8):1169-79. PubMed ID: 25832874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pazopanib as third line therapy for metastatic renal cell carcinoma: clinical efficacy and temporal analysis of cytokine profile.
    Pal SK; Hossain DM; Zhang Q; Frankel PH; Jones JO; Carmichael C; Ruel C; Lau C; Kortylewski M
    J Urol; 2015 Apr; 193(4):1114-21. PubMed ID: 25286010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What next? Choosing second-line therapy in progressive renal cell carcinoma.
    Bourlon MT; Kessler ER
    Oncology (Williston Park); 2014 Sep; 28(9):794-6. PubMed ID: 25225803
    [No Abstract]   [Full Text] [Related]  

  • 17. Pazopanib for the treatment of metastatic renal cell carcinoma.
    Pick AM; Nystrom KK
    Clin Ther; 2012 Mar; 34(3):511-20. PubMed ID: 22341567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of pazopanib in the treatment of renal cell carcinoma.
    Zivi A; Cerbone L; Recine F; Sternberg CN
    Expert Opin Drug Saf; 2012 Sep; 11(5):851-9. PubMed ID: 22861374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal tumoral lesion: challenge. Cutaneous metastasis of renal cell carcinoma.
    Molgó M; Abarzúa Á; Giesen L; González S
    Am J Dermatopathol; 2015 May; 37(5):405, 423-4. PubMed ID: 25893748
    [No Abstract]   [Full Text] [Related]  

  • 20. Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes.
    Xu CF; Bing NX; Ball HA; Rajagopalan D; Sternberg CN; Hutson TE; de Souza P; Xue ZG; McCann L; King KS; Ragone LJ; Whittaker JC; Spraggs CF; Cardon LR; Mooser VE; Pandite LN
    J Clin Oncol; 2011 Jun; 29(18):2557-64. PubMed ID: 21576632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.